Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:6-9
doi: 10.1161/CIRCULATIONAHA.107.710970
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ornato, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ornato, J. P.
Related Collections
Right arrow CPR and emergency cardiac care
Right arrow Acute myocardial infarction
Right arrowRelated Article

(Circulation. 2007;116:6-9.)
© 2007 American Heart Association, Inc.


Editorial

The ST-Segment–Elevation Myocardial Infarction Chain of Survival

Joseph P. Ornato, MD

From the Department of Emergency Medicine, Virginia Commonwealth University, Richmond.

Correspondence to Joseph P. Ornato, MD, Virginia Commonwealth University, Department of Emergency Medicine, 1201 East Marshall St, AD Williams 2nd Floor, Richmond, VA 23298-0401. E-mail ornato@aol.com


Key Words: Editorials • infarction • myocardium


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The benefit of expertly performed, timely, primary percutaneous coronary intervention (PCI) over fibrinolysis is clear for patients with ST-segment–elevation myocardial infarction (STEMI). Primary PCI is superior to fibrinolysis for reduction of overall short-term mortality, nonfatal reinfarction, stroke, and the combined end point of death, nonfatal reinfarction, and stroke.1 These results remain valid during long-term follow-up and are independent of both the type of fibrinolytic used and whether the patient is transferred for primary PCI.

Article p 67

Although the relationship between time delay from hospital emergency department arrival to fibrinolytic treatment and increasing mortality has been firmly established,2 a similar relationship for primary PCI treatment has been proven only recently. De Luca et al3 assessed the relationship between ischemic time and 1-year mortality in 1791 primary PCI-treated STEMI patients. After adjustment for age, gender, diabetes, and previous revascularization, these investigators showed that every 30 minutes of primary PCI treatment delay is associated with a 7.5% (95% CI, 1.008 to 1.15; P=0.041) relative increase in 1-year mortality. With use of hierarchical models adjusted for patient characteristics to evaluate the effect of door-to-balloon time on in-hospital mortality on 29 222 PCI-treated STEMI patients treated in ≤6 hours of presentation at 395 hospitals that participated in the National Registry of Myocardial Infarction–3 and –4 from 1999 to 2002, McNamara et al4 found that a longer door-to-balloon time interval is associated with increased in-hospital mortality. Adjusted for patient characteristics, patients with a door-to-balloon time interval >90 minutes were more likely to die (odds . . . [Full Text of this Article]


Related Article:

Issue Highlights
Circulation 2007 116: 1. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
G. Guagliumi
Emerging data and decision for optimizing STEMI management: the European perspective
Eur. Heart J. Suppl., June 1, 2009; 11(suppl_C): C19 - C24.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Improving Door-to-Balloon Time for Patients with ST-Segment-Elevation MI
Journal Watch Cardiology, August 1, 2007; 2007(801): 1 - 1.
[Full Text]